expertresearchanalysis

[expertresearchanalysis]

Oligonucleotide Synthesis Market Worth USD 8.2 billion by 2024

The rising demand for synthesized oligos in molecular diagnostics and therapeutics, increasing R&D expenditure by pharmaceutical and biotechnology companies, rising venture capital investments, and the increasing demand for synthetic genes are the major factors driving the growth of oligonucleotide synthesis market. Therapeutic Application to Dominate the Global Oligonucleotide Synthesis Market: Therapeutic Application: 1. DNA and Antisense Oligonucleotide-based Therapies 2. RNAi Oligonucleotide-based Therapies 3. CpG Oligonucleotide-based Therapies The therapeutic applications segment, which is further segmented into RNAi oligonucleotide-based therapies, DNA and antisense oligonucleotide-based therapies, and CpG oligonucleotide-based therapies, is estimated to witness the highest growth during the forecast period. This can primarily be attributed to the investments made by companies to explore the therapeutic applications of oligos. Also, from 2016 to 2018, more than five oligonucleotide-based therapies were approved by the FDA. In 2018, these oligonucleotide-based drugs generated a revenue of ~USD 2 billion. Apart from this, there are a couple of oligonucleotide-based drugs in Phase III and FDA review, and these drugs might be launched in the next five years and may positively impact this market. The global oligonucleotide synthesis market is projected to reach USD 8.2 billion by 2024 from USD 4.3 billion in 2019, at a CAGR of 13.7%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=200829350 Recent Developments in Oligonucleotide Synthesis Market: 1. In Febuary 2019, Thermo Fisher Scientific entered into an agreement with BioNTech (Germany). Under the terms of this agreement, BioNTech's messenger RNA (mRNA) manufacturing platform will be supported by Thermo Fisher through the supply of nucleotides, enzymes, and other critical raw materials 2. In Febuary 2019, IDT expanded its courier zones of free next-day delivery service to scientists based in Cambridge, Oxford, and London. This service expansion will help IDT increase its customer base, and also enable projects to be started and finished sooner. 3. In March 2018, Danaher acquired IDT, whichenhanced Danaher’s Life Sciences platform and expanded its customer base. The Objective of Research is as Follows: 1. To define, describe, and forecast the global oligonucleotide synthesis market on the basis of product, application, end user, and region. 2. To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities and industry-specific challenges). 3. To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market. 4. To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for the market leaders. 5. To forecast the size of the market with respect to five regions: North America, Europe, Asia Pacific, and the Rest of the world. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=200829350 Key Players and Strategies Adopted by Them: The prominent players operating in this market include Agilent Technologies, Inc. (US), ATDBio Ltd. (UK), Bio-Synthesis, Inc. (US), BioAutomation Corporation (US), LGC Biosearch Technologies (US), Biogen International (US), Sarepta Therapeutics (US), Eurofins Genomics (Germany), Eurogentec (Belgium), GeneDesign, Inc. (Japan), GE Healthcare (US), GenScript, Inc. (US), Integrated DNA Technologies (IDT, US), Nitto Denko Avecia, Inc. (US), Sarepta Therapeutics (US), Thermo Fisher Scientific, Inc. (US), TriLink BioTechnologies (US), and Sigma-Aldrich Corporation (US) (a part of Merck KGAA).

[expertresearchanalysis]

Enteral Feeding Formulas Market Worth USD 5.95 Billion

The global enteral feeding formulas market is mainly driven by the rising incidences of chronic diseases and disorders, rapidly growing geriatric population, increasing healthcare expenditure, rising prevalence of preterm births, and increasing demand for homecare. However, factors such as complications associated with enteral nutrition, patient safety risks, and the occurrence of feeding and medication errors are expected to restrain the growth of the enteral feeding formulas market to a certain extent. The global enteral feeding formulas market is projected to reach USD 5.95 Billion, at a CAGR of 7.6%. The Oncology Application to Dominate The Enteral Feeding Formulas Market: The oncology application segment held the largest share of the enteral feeding formulas market in 2015, primarily due to high prevalence of malnutrition among cancer patients. Hospitals are the largest end users of enteral feeding formulas, followed by long-term care facilities. Growth in these end-user markets can mainly be attributed to the rapidly growing geriatric population and increasing prevalence of chronic disease and disorders. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=74876393 Other applications primarily include diseases and disorders of the heart, renal system, lungs, and liver, along with psychiatric disorders. Enteral feeding formulas are nutritional replacement products that assist in the nutritive and metabolic processes of the body, in order to maintain adequate weight and strength corresponding to the overall health status of an individual. These formulas are extensively used in hospitals and long-term care facilities. Geographic Growth and Demand Analysis: Geographically, the market in North America and Europe is growing at a significant rate owing to the rising geriatric population along with increasing incidences of chronic diseases and disorders, increasing healthcare expenditure, and increasing demand for homecare in these regions. The Asia-Pacific region however is expected to become the growth center for the enteral feeding formulas market. The market in Japan, China, and India is likely to witness significant growth during the forecast period, owing to the presence of a large patient pool for chronic diseases and disorders, high incidences of preterm births, growing healthcare expenditure. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=74876393 Key Players and Growth Strategies Adopted by Them: The major players in the global enteral feeding formulas market accounted for more than half of the market share. In order to maintain their market shares, major players focus on new product launches expansions, partnerships, agreements, and collaboration and acquisitions as key growth strategies. Of all these strategies, new product launches and expansions were the key strategies adopted by the major market players. Some of the prominent players in the global enteral feeding formulas market are Abbott Laboratories (U.S.), Nestlé S.A. (Switzerland), Danone S.A. (France), Fresenius Kabi AG (Germany), Mead Johnson Nutrition Company (U.S.), B. Braun Melsungen AG (Germany), Hormel Foods, LLC (U.S.), Victus Inc. (U.S.), Meiji Holdings Co., Ltd. (Japan), and Global Health Product Inc. (U.S.).

[expertresearchanalysis]

Molecular Spectroscopy Market: Pharmaceutical Industry is The Future of Global Market

The growth of molecular spectroscopy market is majorly driven by food safety concerns, the growth of the pharmaceutical and biotechnology industry, technological advancements in molecular spectroscopy and application of molecular spectroscopy in environmental screening. However, the high cost of equipment is likely to restrain the growth of the market during the forecast period. The global molecular spectroscopy market is expected to reach USD 6.85 billion by 2022 from USD 4.98 billion in 2017, at a CAGR of 6.6%. The Pharmaceutical Application to Dominate The Industry: Based on application, the molecular spectroscopy market is segmented into pharmaceutical applications, environmental testing, food and beverage testing, biotechnology and biopharmaceutical application, academic research and other applications. During the forecast period, the pharmaceutical application is expected to grow at the highest CAGR. This growth is mainly due to the growing importance of molecular spectroscopy in various stages of drug development and increasing R&D in pharmaceutical industries. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=50034395 The Objective of Research is as Follows: 1. To define, describe, and forecast the global molecular spectroscopy market on the basis of product, application, end user, and region. 2. To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities and industry-specific challenges). 3. To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market. 4. To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for the market leaders. 5. To forecast the size of the market with respect to five regions: North America, Europe, Asia Pacific, and the Rest of the world. Regional Analysis: Asia Pacific to witness the highest growth during the forecast period Asia Pacific is expected to grow at the highest CAGR in the global molecular spectroscopy market during the forecast period of 2017–2022. Thriving biotechnology market in China, growing focus on environmental protection, growing biomedical and medical research in Japan, and rising food safety concerns in India are expected to drive market growth during the forecast period. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=50034395 Key Players: Bruker (US), Thermo Fisher Scientific, Inc. (U.S), PerkinElmer, Inc. (US), Agilent Technologies, Inc. (US), Shimadzu Corporation (Japan), Danaher Corporation (US), ABB (Switzerland), Merck KGaA (Germany), JEOL Ltd. (Japan), FOSS (Denmark), JASCO, Inc. (US), and HORIBA Ltd. (US)

[expertresearchanalysis]

Radiotherapy Market: Key Players, Segmentation, Growth Analysis Worth USD 6.8 billion

Radiotherapy Market growth is largely driven by factors such as technological advancements, the rising prevalence of cancer, the increasing number of conferences and symposia focusing on spreading awareness about the benefits of radiotherapy, and the growing use of particle therapy for cancer treatment. The emerging markets, growing government and private investments to meet the increasing demand for cancer treatment, and the improving reimbursement scenario are expected to present a wide range of growth opportunities for market players. The radiotherapy market is projected to grow from an estimated USD 5.6 billion in 2018 to USD 6.8 billion by 2023, at a CAGR of 4.1%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=567 Global Radiotherapy Market is Segmented by: 1. Type 2. Product 3. Application 4. End User 5. Region By Type: 1. External Beam Radiotherapy 2. Internal Beam Radiotherapy/Brachytherapy 3. Systemic Radiotherapy By Product: 1. LINAC 2. CyberKnife 3. Gamma Knife 4. Tomotherapy 5. Particle Therapy 6. Cyclotron By Application: 1. Prostate Cancer 2. Breast Cancer 3. Lung Cancer 4. Head and Neck Cancer 5. Colorectal Cancer 6. Others cancers (spine cancer, brain cancer, and pediatric cancer, among others)

By End User: 1. Hospitals 2. Independent Radiotherapy Centers. By Region: 1. North America 2. Europe 3. Asia Pacific 4. Rest of The World Asia Pacific is expected to grow at the fastest rate in the radiotherapy market during the forecast period The Asia Pacific is one of the major revenue-generating regions in the radiotherapy market. China, India, and Japan are the major countries responsible for the high growth of this regional market owing to factors such as the increasing per capita income, improving healthcare infrastructure, and supportive government activities in these emerging countries. Furthermore, the increasing geriatric population, the growing incidence of cancer, and the rising acceptance of radiotherapy procedures and devices are also driving the growth of this regional market. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=567 Key Players: Varian Medical Systems, Inc. (US), Elekta AB (Sweden), and Accuray Incorporated (US) dominated the radiotherapy market. Other players in this market include Ion Beam Applications SA (Belgium), ViewRay, Inc. (US), IsoRay Medical, Inc. (US), Hitachi Ltd. (Japan), Panacea Medical Technologies Pvt. Ltd. (India), Provision Healthcare (US), and Mevion Medical Systems, Inc. (US)

[expertresearchanalysis]

The Global Biosurgery Market by Product, Application and Region Worth USD 15.58 billion

The major factors that are expected to be driving the biosurgery market are the rising geriatric population, increase in the volume of surgeries and sports-related and trauma injuries, increasing clearance of biosurgery products by regulatory authorities and growing need for effective blood loss management in patients. The objective of the report is to define, describe, and forecast the biosurgery market size based on product, application, and region. The biosurgery market to grow from USD 11,365.0 million in 2018 to USD 15,581.7 million by 2023, at a Compound Annual Growth Rate (CAGR) of 6.5%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166922302 Biosurgery Market by Product: 1. Bone-Graft Substitutes 2. Soft-Tissue Attachments 3. Hemostatic Agents 4. Surgical Sealants and Adhesives 5. Adhesion Barriers 6. Staple-Line Reinforcement Agents Applications of Biosurgery Market: 1. Orthopedic Surgery 2. General Surgery 3. Neurological Surgery 4. Cardiovascular Surgery 5. Reconstructive Surgery 6. Gynecological Surgery 7. Urological Surgery 8. Thoracic Surgery Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=166922302 Geographical Analysis: 1. North America 2. Europe 3. Asia Pacific 4. Latin America 5. Middle East and Africa North America is expected to hold the largest market size in the biosurgery market during the forecast period. The highest market share of North America is due to the presence of a well-developed healthcare system, increasing volume of surgical procedures performed, large number of hospitals, and presence of leading market players in the region. The Asia Pacific market is expected to witness the highest growth rate during the forecast period. Key Players: Baxter International (US), Johnson & Johnson (J&J) (US), Medtronic plc (Ireland), Sanofi (France), C.R. Bard (US), Integra LifeSciences (US), and Maquet holdings (Sweden), lead the global biosurgery market. Some of the other leading players in this market include Cohera Medical (US), Hemostasis LLC. (US), Stryker Corporation (US), B.Braun Melsungen AG (Germany), CSL Limited (Australia), Pfizer Inc. (US), and Cryolife Inc. (US).

[expertresearchanalysis]

Temperature Monitoring System Market Growth, Size, Share and Industry Segments Analysis

Growth in the temperature monitoring system market is mainly driven by the rising manufacturing activity across a range of industries, stringent regulations to ensure product quality (particularly in the food & beverage and pharmaceutical sectors), and technological advancements. The temperature monitoring system market is projected to grow from USD 4.5 billion in 2019 to USD 5.4 billion by 2024, at a CAGR of 3.9%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=250125379 Global Temperature Monitoring System Market Is Segmented on: 1. Product 2. Application 3. End User 4. Region Temperature Monitoring System Product: Non-contact-based temperature monitoring systems do not require direct contact with the intended energy source/object whose temperature needs to be measured. Based on type, the non-contact-based temperature monitoring systems market is further classified into pyrometers & IR thermometers, thermal imagers, and fiber optic thermometers. Growth in the non-contact-based temperature monitoring systems segment can be attributed to factors such as increasing emphasis on continuous temperature monitoring, growing number of manufacturing and R&D activities, and advantages of contact-based temperature monitoring systems. Application of Temperature Monitoring System Market: Based on application, the hospital and Patient Temperature Monitoring segment is estimated to account for the largest share in the market owing to the rising prevalence of infectious diseases, increasing geriatric and pediatric population, increasing number of surgical procedures, and the rising demand for advanced temperature monitoring devices. Regional Growth and Demand Analysis: North America is one of the major revenue-generating regions in the global temperature monitoring systems industry. The large share of this regional segment can mainly be attributed to the presence of stringent regulatory guidelines and extensive regulatory compliance for product quality among target end-user industries, strong presence of major market players in the region, growing research pipeline among biopharmaceutical companies, and stringent regulatory norms for drug development and food & product safety regulations. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=250125379 Key Players: Some of the prominent players in the temperature monitoring systems are 3M (US), Abb Ltd. (Switzerland), Deltatrack (US), Emerson Electric (US), Fluke Corporation (US), and Omega Engineering (US). 3M is among the significant players in the temperature monitoring systems market with its strong presence, unique product portfolio, and wide distribution network. The company has a significant share in the patient temperature monitoring systems segment. The company offers core temperature monitoring systems for preoperative testing. In order to increase awareness among end users, the company launched a compendium with the latest information and research findings related to its Bair Hugger.

[expertresearchanalysis]

Temperature Management Market Worth USD 3 billion | Analysis of COVID 19 Impact

Some of the major factors driving the growth of temperature market include the increasing incidence of chronic conditions and increasing number of surgical procedures. However, the high cost of intravascular temperature management systems is restraining the growth of this market. The global temperature management market is projected to reach USD 3.0 billion in 2024 from 2.6 billion in 2019, at CAGR of 3.2%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=141546773 Global Temperature Management Market is Segmented on: 1. Product 2. Application 3. Medical Specialities Temperature Management Market Product: Patient cooling systems are expected to register the highest growth in the forecast period. This growth can be attributed to factors such as the growing demand for these systems in diverse hospital settings and the increasing adoption of invasive warming in surgical procedures such as orthopedic surgeries, gynecological & obstetric procedures, gastrointestinal procedures, and general surgeries. Applications of Temperature Management Market: The acute care segment is expected to grow at the highest CAGR during the forecast period. Acute care encompasses specialized care and the support given to patients during emergencies or after undergoing surgeries in hospitals including intensive care units (ICUs), emergency rooms, coronary care units (CCUs), neurological care units, burn centers, and cath labs. The increase in the number of surgical procedures, growth in geriatric population, and increasing number of product launches are driving the growth of the acute care segment. Medical Specialities (Orthopedic Surgery): The growing number of knee and hip replacement procedures, rising prevalence of arthritis, sedentary lifestyles, increasing prevalence of musculoskeletal disorders, and the increasing number of sports injury cases are the key factors driving the growth of the orthopedic surgery segment. The increasing number of orthopedic surgical procedures will increase the demand for temperature management systems which will contribute to the growth of the segment. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=141546773 Geographic Analysis of Temperature Management Industry: North America accounted for the largest share of this market, followed by Europe. The large share of this regional segment is mainly due to the large volume of surgical procedures performed in North American countries. On the other hand, the market in the Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Factors such as the growing demand for aesthetic and medical surgeries, rising incidence of cardiac arrests and CNS disorders, government efforts to increase access to elective surgeries, and improving healthcare infrastructures are the major factors supporting the growth of the Asia Pacific market.

[expertresearchanalysis]

Healthcare Analytical Testing Services Market Driven by End Users Worth USD 5.97 billion

The shift of focus towards analytical testing of biologics and biosimilars, increasing outsourcing of analytical testing by pharmaceutical companies, increasing acceptance of the QbD approach in pharma research/manufacturing, and adoption of FTE contracts in R&D outsourcing are the major factors driving the growth of the healthcare analytical testing services market. The global healthcare analytical testing services market is projected to reach USD 5.97 Billion by 2023 from USD 3.43 Billion in 2018, at a CAGR of 11.7%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=108923833 Global Healthcare Analytical Testing Services Market is Segmented on: 1. Type 2. End User 3. Region Type: On the basis of type, the bioanalytical testing segment accounted for the largest share of the global healthcare analytical testing servicess market in 2017. The large share of this segment is due to increasing number of drugs in the biopharmaceutical pipeline and the growing biopharmaceutical industry. End User: The global healthcare analytical testing services market by end user is segmented into pharmaceutical and biopharmaceutical companies, medical device companies and contract research organizations. In 2017, the pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the market. The large share of this segment can be attributed to the increasing outsourcing of analytical testing services by pharmaceutical and biopharmaceutical companies to boost profit margins, avoid high capital expenditure, and reduce the time required to validate the process and product. Regional Analysis: Geographically, the global healthcare analytical testing services market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2017, North America accounted for the largest share of the healthcare analytical testing services market, followed by Europe and Asia Pacific. The presence of a well-established pharmaceutical industry in the region, coupled with the high R&D expenditure, growth in the Biosimilars and generics markets, increasing number of analytical testing service providers, and rising outsourcing of analytical testing by biopharmaceutical companies are the major factors driving the growth of the healthcare analytical testing services market in North America. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=108923833 Key Players: The prominent players in the global healthcare analytical testing services market are Eurofins Scientific (Luxembourg), Wuxi PharmaTech (China), Charles River Laboratories (US), Almac Group (UK), Exova Group (UK), PPD (US), Source BioScience (UK), Anabiotec (Belgium), Intertek Group (UK), and BioReliance (US).

[expertresearchanalysis]

Diagnostic Imaging Services Market Worth USD 693.4 billion Driven by Emerging Market in Asia Pacific

The major factors driving the growth of diagnostic imaging services market include the rapidly growing geriatric population and the subsequent increase in the prevalence of associated diseases and growing awareness about early disease detection and the widening scope of clinical applications. Diagnostic Imaging Services Market by Procedure (MRI, Ultrasound, X-RAY, CT, Nuclear Imaging (SPECT, PET), Mammography), Application (OB/Gyn, Orthopedics, Oncology, Vascular, Neurology), End User (Hospitals, Imaging Centers) The diagnostic imaging services market is projected to reach USD 693.4 billion by 2024 from USD 539.7 billion in 2019, at a CAGR of 5.1%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=17157849 In 2018, the x-ray segment accounted for the largest share of the diagnostic imaging services market. On the basis of modality, the diagnostic imaging services market is segmented into magnetic resonance imaging (MRI), ultrasound, computed tomography (CT), X-ray, nuclear imaging, and mammography. In 2018, the x-ray segment accounted for the largest share of the market. The key factors driving the growth of this market include the rising geriatric population, lower cost of X-rays as compared to other imaging modalities, favorable returns on investments, and technological advancements in X-ray imaging systems. The Asia Pacific market is expected to grow at the highest CAGR during the forecast period. The diagnostic imaging services market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the RoW. In 2018, North America commanded the largest share of the global diagnostic imaging service market. However, the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period primarily due to the improving healthcare infrastructure, rising investments in diagnostic imaging, improving reimbursement scenario, and the growing insurance coverage in several APAC countries. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=17157849 Key Players and Growth Strategies Adopted by Them: Prominent players in the diagnostic imaging services market include RadNet, Inc (US), Sonic Healthcare (Australia), Dignity Health (US), Novant Health (US), Alliance Medical (UK), InHealth Group (UK), Medica Group (UK), Global Diagnostics (Australia), Healthcare Imaging Services Pty Ltd. (Australia), Concord Medical Services Holdings Limited (China), and Center for Diagnostic Imaging, Inc. (CDI) (US), among others. An analysis of market developments between 2016 and 2019 revealed that several growth strategies such as partnerships & agreements, joint ventures, and strategic acquisitions were adopted by market players to strengthen their service portfolios and maintain a competitive position in the market.

[expertresearchanalysis]

NGS-Based RNA-Sequencing Market Driven by "Growth in Precision Medicine Market"

According to the recent report “NGS-Based RNA-Sequencing Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, small RNA), End-User, Region - Global Forecast to 2024" The NGS-based RNA-sequencing market size is projected to reach USD 4.2 billion by 2024 from USD 1.7 billion in 2019, at a CAGR of 20.0% during the forecast period. Browse in-depth TOC on “NGS-Based RNA-Sequencing Market” 87 – Tables 38 – Figures 156 – Pages Market growth is driven mainly by the advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=102977816 The expression profiling analysis segment accounted for the largest share of the NGS-based RNA-sequencing market, by application, in 2018 Based on application, the NGS-based RNA sequencing market is segmented into expression profiling analysis, small RNA sequencing, De Novo transcriptome assembly, and variant calling & transcriptome epigenetics. In 2018, the expression profiling analysis segment accounted for the largest share of the NGS-based RNA sequencing market. The dominant market position of this segment is attributed mainly to the increasing prevalence of metabolic disorders, multiple sclerosis, and other diseases. These factors will continue to propel the demand for expression profiling analysis to provide specific treatment options in the market during the forecast period. The nanopore segment is expected to register the highest growth in the NGS-based RNA-sequencing market, by type, during the forecast period Based on technology, the NGS-based RNA-sequencing industry is segmented into sequencing by synthesis, ion semiconductor sequencing, single molecular real-time sequencing, and nanopore sequencing. Nanopore sequencing technology registers the highest growth rate in the market as it is the only sequencing technology with direct RNA-sequencing capabilities and facilitates sequencing of full-length RNA strands and modified RNA nucleotides using a simple library prep, without the need of conversion to double-stranded DNA. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=102977816 North America dominated the NGS-based RNA-sequencing market North America accounted for the largest share of the market in 2018. The large share of this region is the growing prevalence of target diseases, government support through funds for genomics research, advancements in RNA-Seq products, increasing research on cancer & inherited rare diseases, and the strong presence of key players such as Illumina (US), Thermo Fisher (US), and Agilent Technologies (US) in this region.

[expertresearchanalysis]

Global NGS-based RNA-seq Market | Growth, Key Segments and Business Analysis

The global NGS-based RNA-seq market is projected to reach USD 2.65 billion by 2022 from USD 1.05 billion in 2017, at a CAGR of 20.2%. Factors such as the advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid growth in precision medicine are driving the growth of the NGS-based RNA-seq market. On the other hand, accuracy and standardization concerns in diagnostic testing and the lack of skilled technical personnel are some of the key factors limiting the growth of the market. Market Segments: In 2016, the sequencing platforms and consumables segment is expected to account for the largest share of the market. The data analysis, storage, and management is expected to register the highest growth rate owing to its development of more efficient data analysis solutions and growing computational capabilities of data analytics providers. Research centers and academic & government institutes segment accounted for the largest share of the global market in 2016 due to the increasing focus of market players on providing efficient RNA-seq products & services for research applications and the growing number of government funding programs. However, the hospitals and clinics segment is expected to register the highest growth due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics. Based on applications, the market is categorized into four segments, namely, de novo transcriptome assembly, expression profiling analysis, variant calling & transcriptome epigenetics, and small RNA sequencing. The expression profiling analysis segment accounted for the major share of the global NGS-based RNA-seq market owing to the technological advantages of expression profiling applications. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=102977816 Largest and Fastest Geographical Market: Geographically, the NGS-based RNA-seq market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounted for the largest share of the market in 2016, followed by Europe and Asia-Pasific. However, Asia-Pacific is expected to register the highest growth rate during the forecast period from 2017 to 2022, owing to focus on R&D activities and the low cost of NGS products & services in this region. Growth Strategies: The global NGS-based RNA-seq market is highly competitive, with a large number of global and local players. In 2016, the market was dominated by Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Pacific Biosciences of California, Inc. (U.S.). Product launches, agreements, and partnerships were the major strategies adopted by market players to achieve growth in the market. Research Coverage: This report studies the NGS-based RNA-seq market based on product & service, application, technology, and end user. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions. Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=102977816

[expertresearchanalysis]

Emergence of Microfluidics Key Opportunity In 3D Cell Culture Market

Cell culture is an important tool for research and development in the life sciences industry. While most researchers still rely on the conventional, two-dimensional (2D) cell culture method, the 3D cell culture model is gaining popularity among researchers in recent years due to the benefits this model offers over the conventional method. 2D cell culture involves growing cells on a flat surface called 2D monolayers. This method limits the formation of multi-dimensional cell cultures. In the 3D cell culture method, on the other hand, biological cells are allowed to grow or interact with their surroundings in all three dimensions. This method enables cells to grow in vitro; these surroundings better mimic the in vivo conditions in which the cells are naturally present. The 3D cell culture technique has proven to be very efficient in several studies of basic biological mechanisms such as cell number monitoring, cell viability, cell proliferation, cell morphology, and so on. Moreover, 3D cell cultures have greater stability and longer lifespans compared to 2D cell cultures. Owing to the benefits offered by the 3D cell culture model, these techniques are being widely adopted in cancer research studies. Cancer cells grown in 2D cell cultures can be easily destroyed by low dosage radiation, while the same cells grown in 3D cell cultures are far more resistant to low radiation doses, thus mimicking an in vivo environment. Therefore, 3D cell culture technique is considered a more practical approach for testing and discovering new drugs to treat cancer. Recent technological advances have also enabled the use of microfluidics in 3D cell culture for the development of microenvironments that support tissue differentiation and replicate the tissue-tissue interface, spatiotemporal chemical gradients, and mechanical microenvironments of living organs. This organ-on-a-chip model enables the study of the human physiology in an organ-specific context, which allows the development of in vitro disease models and can eventually serve as a replacement for animal models in drug development and toxicity testing. Owing to these benefits, the adoption of microfluidics for 3D cell culture studies is expected to grow in the coming years. Mimetas, Emulate, and InSphero are some of the key players actively involved in the research and development of microfluidics for 3D cell cultures. Download Free Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=191072847 Apart from the opportunities presented by microfluidics-based 3D cell culture, 3D cell printing is another noteworthy addition to the 3D cell culture market. 3D cell printing uses inkjet-like nozzles to deposit cells into defined structures. The technique uses 3D printing to produce organ models. Several universities and companies, such as BioBots, and Organovo, are working towards the development of 3D-printed organ models. The 3D cell culture market is competitive, with a large number of market players, including established players, mid-tier companies, and startup firms. Prominent players in the market include Thermo Fisher Scientific, Corning, Merck KGaA, Lonza, ReproCELL, InSphero, Global Cell Solutions, Synthecon, 3D Biotek LLC, Kuraray, Hamilton, Mimetas, Emulate, Nano3D Biosciences, Q Gel, Microtissues, Matek, Nano Fiber Solutions, and Cosmo Bio Japan. To strengthen their market presence, these players adopted various inorganic and organic growth strategies such as agreements, partnerships, and collaborations; product launches/upgrades; patent approvals; expansions; and mergers and acquisitions. Researchers around the world are realizing the potential of the 3D cell culture method for various applications, which is why the 3D cell culture market is likely to grow over the next few years. According to a recent research study published by MarketsandMarkets, the global 3D cell culture market is projected to reach USD 1,720.3 million by 2022 from USD 682.8 million in 2017, at a CAGR of 20.3% during the forecast period (2017–2022). Growth in this market is also driven by global factors such as the focus on developing alternative methods to animal testing, funding initiatives from governments and private investors, technological advancements, and regular product launches. Growing awareness about 3D cell culture via conferences, workshops, trade fairs, and forums also contributes to market growth. Read more: https://www.marketsandmarkets.com/PressReleases/3d-cell-culture.asp

[expertresearchanalysis]

Optometry Exam Equipment Market | Growth Insights

Rising prevalence of eye diseases, technological advancements in ophthalmic devices, increasing government initiatives to control visual impairment, and increasing healthcare expenditure and rising disposable incomes are some of the major factors driving the growth of Optometry Exam Equipment Market. The retina and glaucoma examination products segment is expected to register the highest CAGR during the forecast period. The high growth of this segment is attributed to the growing prevalence of retinal diseases and glaucoma, increasing number of eye care clinics, technological advancements in eye exam equipment, and growing access to modern ophthalmic diagnostic devices. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=14475790 The large share of the clinics segment can be attributed to factors such as the large patient pool treated in clinics and the increasing number of private clinical practices established by ophthalmologists in emerging countries. The Asia Pacific region is expected to witness the highest CAGR during the forecast period, owing to the rapid growth in the geriatric population, increasing number of patients suffering from diabetes, improving healthcare infrastructure, rising awareness regarding advanced procedures among people in this region, and growing per capita income in the region. The report analyzes the various eye exam equipment and their adoption patterns in the market. It aims at estimating the market size and future growth potential of the global eye exam equipment market for different segments such as type, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies. Read more: https://www.marketsandmarkets.com/PressReleases/optometry-eye-exam-equipment.asp Moreover, the study showcases back-to-back parameters like application, improvement, product growth, and diverse structures & key processes. The report highlights the in-depth analysis of various critical parameters such as profit & loss statistics, product value, production capability, production process, and many more. The Optometry Exam Equipment Market report delivers a perfect solution, which incorporates current market intelligence, future projections for the growth, technology inputs, and future market trends. The report focuses on key strategic developments, analytical tools, and market feature. The report exhibits a top to the bottom estimate of the Optometry Exam Equipment Market which includes key patterns, key players, market drivers, challenges, arrangement patterns, openings, esteem chain, professional outlines, and future guide. Request free sample pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=14475790

[expertresearchanalysis]

Temperature Monitoring Systems Market

The temperature monitoring systems market in the Asia Pacific is expected to witness the highest CAGR from 2019 to 2024. Factors such the growing food safety concerns, increasing R&D activities, rising government healthcare expenditure, the presence of stringent regulatory policies for food & drug safety, and the growth of the biotechnology and pharmaceutical industries in key APAC countries such as India and China are the major factors driving the growth of this regional segment. This report studies the temperature monitoring systems market based on type, end user, application, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four major regions. The global temperature monitoring systems market is projected to reach USD 5.4 billion by 2024 from USD 4.5 billion in 2019, at a CAGR of 3.9% Moreover, the study showcases back-to-back parameters like application, improvement, product growth, and diverse structures & key processes. The report highlights the in-depth analysis of various critical parameters such as profit & loss statistics, product value, production capability, production process, and many more. The Temperature Monitoring Systems Market report delivers a perfect solution, which incorporates current market intelligence, future projections for the growth, technology inputs, and future market trends. The report focuses on key strategic developments, analytical tools, and market feature. The report exhibits a top to the bottom estimate of the Temperature Monitoring Systems Market which includes key patterns, key players, market drivers, challenges, arrangement patterns, openings, esteem chain, professional outlines, and future guide. Several companies such as 3M (US), Abb Ltd. (Switzerland), Deltatrack (US), Emerson Electric (US), Fluke Corporation (subsidiary of Fortive Corporation) (US), Honeywell (US), Kelsius, Ltd. (Ireland), Monnit Corporation (US), Omega Engineering (US), Rees Scientific (US), and SensoScientific, Inc. are investing in high-growth markets to gain significant profits and increase their share in the global temperature monitoring systems market. Know more: http://www.marketsandmarketsblog.com/temperature-monitoring-systems-market-growth-size-industry-trends.html 

[expertresearchanalysis]

Medical Terminology Software Market | Key Revenue Segment Analysis

The Asia Pacific market is projected to register the highest growth rate in medical terminology software market. Factors such as improving healthcare infrastructure, rising healthcare insurance coverage, and growing medical tourism in the region are driving the growth of the medical terminology software market in the Asia Pacific. Asian countries such as India, China, Malaysia, and Indonesia are in the early stages of adopting healthcare IT solutions including medical terminology solutions, while countries like Australia, New Zealand, and Singapore are at the forefront. The report analyzes the various type of medical terminology software and their adoption patterns. It aims at estimating the market size and future growth potential of the global medical terminology software market for different segments such as application, product& service, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies. The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their presence in the market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=239939409 This report provides insights on the following pointers: Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global medical terminology software market. The report analyzes the global medical terminology software market by application, product & service, end user, and region Product Development/Innovation: Detailed insights on the upcoming trends and new product launches in the global medical terminology software market Market Development: Comprehensive information on the lucrative emerging regions by application, product & service, and end user Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global medical terminology software market Competitive Assessment: In-depth assessment of market ranking, growth strategies, and products of leading players in the global medical terminology software market Objectives of the Study To define, describe, and forecast the medical terminology software market on the basis of product & service, application, end user, and region To provide detailed information about factors influencing market growth (such as drivers, restraints, opportunities, and industry-specific challenges) To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall medical terminology software market To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players To forecast the size of the market segments with respect to five  main regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa To strategically profile key players and comprehensively analyze their core competencies in the medical terminology software market To track and analyze competitive developments such as partnerships, agreements, collaborations, alliances, mergers & acquisitions, product launches, expansions, and R&D activities in the medical terminology software market The growth in this market is driven by factors such as the rising focus on minimizing medical errors, government initiatives for HCIT adoption, and disparity and fragmentation in the terminology content of healthcare organizations. The increasing need to maintain data integrity is expected to provide further growth opportunities for market players in the coming years. Intelligent Medical Objects (US), Wolters Kluwer (Netherlands), and Clinical Architecture (US) are the major players in this market. These companies mainly focus on product launches, partnerships, and collaborations to strengthen their presence in the medical terminology software market. Moreover, the study showcases back-to-back parameters like application, improvement, product growth, and diverse structures & key processes. The report highlights the in-depth analysis of various critical parameters such as profit & loss statistics, product value, production capability, production process, and many more. The Medical Terminology Software Market report delivers a perfect solution, which incorporates current market intelligence, future projections for the growth, technology inputs, and future market trends. The report focuses on key strategic developments, analytical tools, and market feature. The report exhibits a top to the bottom estimate of the Medical Terminology Software Market which includes key patterns, key players, market drivers, challenges, arrangement patterns, openings, esteem chain, professional outlines, and future guide.

Source: http://www.marketsandmarketsblog.com/medical-terminology-software-market-growth-industry-trends.html

[expertresearchanalysis]

Interventional Oncology Market | Growth, Industry Insights

The interventional oncology market is segmented into five major regions, namely North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Europe accounted for the second-largest share in 2018. The rising incidence of cancer, coupled with the growing geriatric population in Europe, is a key factor propelling the demand for interventional oncology products in this region. Prominent market players are focusing on improving the quality of patient care across Europe by commercializing advanced products, investing in technological innovations, and partnering with other institutions and organizations for spreading cancer awareness. This report studies the interventional oncology market based on products, procedure, cancer type, and region. The report also studies factors such as drivers, restraints, opportunities, and challenges affecting market growth. It also provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and the respective countries in these regions. Growth in the interventional oncology market can be attributed to factors such as the rising preference for minimally invasive procedures, expansion of the target patient population, and increasing public-private funding and government support for cancer research. On the other hand, the dearth of well-trained and skilled radiologists and oncologists, high costs of interventional oncology procedures, and unfavorable regulations are expected to limit market growth to a certain extent. Read more: https://www.marketsandmarkets.com/PressReleases/interventional-oncology.asp This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views. It also analyzes the competitive landscape; emerging segments of the interventional oncology market; and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares. Moreover, the study showcases back-to-back parameters like application, improvement, product growth, and diverse structures & key processes. The report highlights the in-depth analysis of various critical parameters such as profit & loss statistics, product value, production capability, production process, and many more. The Interventional Oncology Market report delivers a perfect solution, which incorporates current market intelligence, future projections for the growth, technology inputs, and future market trends. The report focuses on key strategic developments, analytical tools, and market feature. The report exhibits a top to the bottom estimate of the Interventional Oncology Market which includes key patterns, key players, market drivers, challenges, arrangement patterns, openings, esteem chain, professional outlines, and future guide. The interventional oncology market is projected to reach USD 2.9 billion by 2024 from USD 2.0 billion in 2019, at a CAGR of 6.8%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203687164 The major players operating in the interventional oncology market include BTG plc (UK), Medtronic (Ireland), Boston Scientific (US), Terumo (Japan), Merit Medical (US), Sirtex (China), AngioDynamics (US), Ethicon (US), Teleflex (US), Cook Medical (US), HealthTronics (US), MedWaves (US), Sanarus (US), IMBiotechnologies (Canada), Trod Medical (US), IceCure Medical (Israel), Mermaid Medicals (Denmark), Interface Biomaterials BV (Netherlands), Guerbet (France), ABK Biomedical (Canada), Shape Memory Medical (US), Endo Shape (US), Monteris Medical (US), Instylla (US), and Trisalus Lifesciences (US). Know more about key strategies adopted by industry players: https://www.marketsandmarkets.com/ResearchInsight/interventional-oncology-market.asp This research study involved the extensive use of secondary sources, directories, and databases (such as D&B Hoovers, Bloomberg Businessweek, and Factiva), along with government databases, which were used to identify and collect information for this method-based, market-oriented, and commercial study of the interventional oncology market. In-depth interviews were conducted with various primary respondents that mainly include key industry participants, medical practitioners, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants to obtain and verify critical qualitative and quantitative information as well as to assess prospects of the interventional oncology market.

Interventional Oncology Market, by Product

Embolization Devices

Radioembolic Agents

Non-radioactive Embolic Agents

Ablation Devices

Radiofrequency Ablation Devices

Microwave Ablation Devices

Cryoablation Devices

Other Ablation Devices

Support Devices

Microcatheters

Guidewires

Interventional Oncology Market, by Procedure

Thermal Tumor Ablation

Non-thermal Tumor Ablation

Transcatheter Arterial Chemoembolization (TACE)

Transcatheter Arterial Radioembolization (TARE) or Selective Internal Radiation Therapy (SIRT)

Transcatheter Arterial Embolization (TAE) or Bland Embolization

Interventional oncology Market, by Cancer Type

Liver Cancer

Kidney Cancer

Lung Cancer

Bone Cancer

Other Cancers

[expertresearchanalysis]

Immuno Oncology Assays Market | Growth, Industry Trends Insights

The Asia Pacific is projected to record the highest growth rate in immuno oncology assays market. Factors such as growing number of CROs in the region, increasing awareness about early detection of cancer, and the shift of manufacturers’ and suppliers’ focus from developed economies to emerging economies, such as India and China are driving the growth of this regional segment.

Recent Developments:

1 In 2018, Roche collaborated with SQZ Biotech to develop antigen presenting cells-based immune-oncology treatments.

2 In 2018, Illumina launched its TruSight Oncology 500 assay, which is used to identify known and emerging tumor biomarkers.

3 In 2018, Roche acquired Tusk Therapeutics to expand its oncology product portfolio.

4 In 2018, Agilent acquired ACEA Biosciences (US). This acquisition will help both the companies to focus on real-time, live-cell analyzes through their expertise in cellular function and metabolism measurements.

5 In 2016, Thermo Fisher collaborated with Invivoscribe Technologies to develop NGS-based in vitro diagnostic oncology tests. The market study covers the immuno oncology assays market across various segments. It aims at estimating the market size and the growth potential of this market across different segments, on the basis of product, technology, application, indication, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies. The market for immuno-oncology assays is expected to reach USD 5.9 billion by 2024 from USD 2.9 billion in 2018, at a CAGR of 12.7%. Read more: https://www.marketsandmarkets.com/PressReleases/immuno-oncology-assays.asp Moreover, the study showcases back-to-back parameters like application, improvement, product growth, and diverse structures & key processes. The report highlights the in-depth analysis of various critical parameters such as profit & loss statistics, product value, production capability, production process, and many more. The Immuno Oncology Assays Market report delivers a perfect solution, which incorporates current market intelligence, future projections for the growth, technology inputs, and future market trends. The report focuses on key strategic developments, analytical tools, and market feature. The report exhibits a top to the bottom estimate of the Immuno Oncology Assays Market which includes key patterns, key players, market drivers, challenges, arrangement patterns, openings, esteem chain, professional outlines, and future guide. Key Market Players: The key players operating in the immuno-oncology assays market are Thermo Fischer Scientific (US), Roche Diagnostics (Switzerland), Agilent Technologies (US), and Illumina (US). A majority of the leading players in the market focus on both organic and inorganic growth strategies such as collaborations, partnerships, acquisitions, and agreements to maintain and enhance their market shares in the immuno-oncology assays market. Know more about key strategies adopted by industry players: https://www.marketsandmarkets.com/ResearchInsight/immuno-oncology-assays-market.asp